400-115-0588
在线咨询产品分类
快速订购
31952518
- 029-86354885
- 18392009562
sales@xarxbio.com
Home >
Products > APIs cancer> Hot APIs cancer> AP24534; AP-24534; AP 24534; Ponatinib HCl; Ponatinib hydrochloride,CAS1114544-31-8
AP24534; AP-24534; AP 24534; Ponatinib HCl; Ponatinib hydrochloride,CAS1114544-31-8
| Catalog # | Pkg Size | Price | Quantity | Shopping Cart |
|---|---|---|---|---|
| R-SX-793 | 1 | ￥ 1 | 加入购物车 | |
Datasheet
MSDS
COA
结构式
| 外观 | N/A |
| 分子量 | 569.02 |
| 溶解度 | N/A |
| CAS号 | 1114544-31-8 |
| 质量控制 | N/A |
| 储存条件 | N/A |
| 保存时间 | N/A |
| 其他信息 | 价格1，就是价格现询 |
ponatinib, also known as AP24534 is an oral drug for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL). It is a multi-targeted tyrosine-kinase inhibitor. Some forms of CML, those that have the T315I mutation, are resistant to current therapies such as imatinib. Ponatinib has been designed to be effective against these types of tumors. Ponatinib was approved in 2012.西安瑞禧生物提供各种抑制剂材料。
亲，说点什么吧，您的评价对其它买家很有帮助哦~
“好评，中评，差评”请填写其一哦~
您的昵称
库存查询